Neonatal abstinence syndrome: therapeutic interventions

Juli Sublett1

  • 1University Hospital, Neonatal Intensive Care Unit, Cincinnati, OH, USA. juliannsublett@gmail.com

Insights

Neonatal Abstinence Syndrome (NAS) is a severe condition in infants exposed to drugs during pregnancy. This review examines the safety and efficacy of pharmacologic and nonpharmacologic treatments for NAS, highlighting knowledge gaps.

Area of Science:

  • Neonatal Abstinence Syndrome (NAS)
  • Pediatric Pharmacology
  • Neonatal Care

Background:

  • NAS affects infants exposed to opiates/illicit drugs in utero, causing severe symptoms and prolonged hospitalizations.
  • Pharmacologic treatments like methadone, buprenorphine, morphine, and phenobarbital are common but lack fully recognized safety/efficacy data.
  • Nonpharmacologic and complementary therapies are documented but under-researched for neonatal withdrawal.

Purpose of the Study:

  • To provide an overview of pharmacologic and complementary therapies for NAS.
  • To assess the potential risks, benefits, and outcomes of these treatments in neonates.
  • To identify and illustrate gaps in the current literature regarding NAS therapies.

Main Methods:

  • Literature review of pharmacologic interventions for NAS.
  • Review of nonpharmacologic and complementary therapies for neonatal withdrawal.
  • Analysis of existing data on safety, efficacy, and outcomes.

Main Results:

  • Pharmacologic treatments are widely used but their safety and efficacy require further investigation.
  • Nonpharmacologic and complementary therapies show promise but lack comprehensive research.
  • Significant gaps exist in understanding the full spectrum of treatment options and their impact.

Conclusions:

  • Further research is crucial to establish evidence-based guidelines for NAS treatment.
  • A comprehensive understanding of both pharmacologic and nonpharmacologic approaches is needed.
  • Addressing knowledge gaps will improve care and outcomes for infants with NAS.

Related Concept Videos

CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...